Jiangsu Kanion Pharmaceutical Co Ltd Financial Flexibility Index
Jiangsu Kanion Pharmaceutical Co Ltd financial flexibility index. Jiangsu Kanion Pharmaceutical Co Ltd (600557) has a Financial Flexibility Index of 0.18x as of September 2025. Free cash flow of CN¥330.77 Million (operating CF CN¥201.83 Million minus capex CN¥128.94 Million) represents 0% of total liabilities (CN¥1.83 Billion). Explore 600557 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Jiangsu Kanion Pharmaceutical Co Ltd (2001–2024)
Financial flexibility index of Jiangsu Kanion Pharmaceutical Co Ltd from 2001 to 2024. Historical Financial Flexibility Index trend for Jiangsu Kanion Pharmaceutical Co Ltd across 24 annual periods. Check Jiangsu Kanion Pharmaceutical Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Jiangsu Kanion Pharmaceutical Co Ltd Financial Flexibility Index by Year (2001–2024)
Jiangsu Kanion Pharmaceutical Co Ltd financial flexibility index by year from 2001 to 2024. Year-by-year free cash flow to debt coverage for Jiangsu Kanion Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Jiangsu Kanion Pharmaceutical Co Ltd cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.54x | CN¥1.18 Billion | CN¥702.49 Million | CN¥2.20 Billion | ▼ -26.7% |
| 2023 | 0.73x | CN¥1.27 Billion | CN¥972.32 Million | CN¥1.74 Billion | ▲ +12.8% |
| 2022 | 0.65x | CN¥1.21 Billion | CN¥995.94 Million | CN¥1.86 Billion | ▼ -7.2% |
| 2021 | 0.70x | CN¥1.08 Billion | CN¥908.30 Million | CN¥1.55 Billion | ▲ +40.5% |
| 2020 | 0.50x | CN¥891.42 Million | CN¥701.10 Million | CN¥1.79 Billion | ▼ -28.9% |
| 2019 | 0.70x | CN¥1.42 Billion | CN¥925.73 Million | CN¥2.02 Billion | ▲ +25.7% |
| 2018 | 0.56x | CN¥952.12 Million | CN¥636.39 Million | CN¥1.71 Billion | ▲ +55.6% |
| 2017 | 0.36x | CN¥643.87 Million | CN¥382.93 Million | CN¥1.80 Billion | ▼ -12.7% |
| 2016 | 0.41x | CN¥624.26 Million | CN¥299.02 Million | CN¥1.52 Billion | ▼ -34.0% |
| 2015 | 0.62x | CN¥889.59 Million | CN¥514.80 Million | CN¥1.43 Billion | ▲ +59.8% |
| 2014 | 0.39x | CN¥620.91 Million | CN¥311.54 Million | CN¥1.60 Billion | ▼ -20.0% |
| 2013 | 0.49x | CN¥727.33 Million | CN¥388.11 Million | CN¥1.50 Billion | ▲ +53.6% |
| 2012 | 0.32x | CN¥465.99 Million | CN¥212.11 Million | CN¥1.47 Billion | ▼ -8.8% |
| 2011 | 0.35x | CN¥383.72 Million | CN¥90.19 Million | CN¥1.11 Billion | ▼ -42.9% |
| 2010 | 0.61x | CN¥451.29 Million | CN¥166.40 Million | CN¥743.19 Million | ▲ +1952.0% |
| 2009 | 0.03x | CN¥10.87 Million | CN¥-21.87 Million | CN¥367.23 Million | ▼ -92.7% |
| 2008 | 0.41x | CN¥145.08 Million | CN¥58.39 Million | CN¥355.85 Million | ▲ +27.4% |
| 2007 | 0.32x | CN¥151.62 Million | CN¥92.73 Million | CN¥473.81 Million | ▲ +6.2% |
| 2006 | 0.30x | CN¥133.50 Million | CN¥108.98 Million | CN¥443.19 Million | ▲ +3.6% |
| 2005 | 0.29x | CN¥154.82 Million | CN¥101.44 Million | CN¥532.62 Million | ▼ -25.3% |
| 2004 | 0.39x | CN¥144.36 Million | CN¥21.68 Million | CN¥370.88 Million | ▲ +9.2% |
| 2003 | 0.36x | CN¥143.84 Million | CN¥17.13 Million | CN¥403.56 Million | ▼ -66.7% |
| 2002 | 1.07x | CN¥99.22 Million | CN¥11.15 Million | CN¥92.69 Million | ▲ +181.1% |
| 2001 | 0.38x | CN¥39.46 Million | CN¥21.02 Million | CN¥103.61 Million | — |